Abstract

Hospital acquired pneumonia (HAP) and ventilator associated pneumonia (VAP) remain the most frequent nosocomial infection in critical ill patients and bring about higher hospitalization cost, longer length of stay in hospital and increased mortality. In 2016, with advances in evidence-based guideline methodology and analysis of new studies related to the diagnosis and treatment of HAP and VAP, Infectious Diseases Society of America (IDSA) and American Thoracic Society (ATS) have collaborated to create updated guidelines for the diagnosis and treatment of HAP and VAP based on last HAP/VAP guidelines published in 2005. Here, we will make a brief introduction of important updates of these new guidelines. Key words: Hospital acquired pneumonia; Ventilator-associated pneumonia; Guidelines

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.